Activation of complement system by mannan pathway and Mbl2 genotypes in patients with type 2 diabetes and nephropathy

<p>To add new evidence that complement activation by the mannan (lectin) pathway is involved in the pathogenesis of nephropathy in patients with type 2 diabetes, we collected blood and urine samples from 20 patients with type 2 diabetes and nephropathy and 20 apparently healthy individuals fro...

Full description

Bibliographic Details
Main Authors: Tjaša Cerar, Draženka Pongrac Barlovič, Anže Zorin, Nadan Gregorič, Vladimir Kotnik
Format: Article
Language:English
Published: Slovenian Medical Association 2014-11-01
Series:Zdravniški Vestnik
Subjects:
Online Access:http://vestnik.szd.si/index.php/ZdravVest/article/view/103
_version_ 1818465657262440448
author Tjaša Cerar
Draženka Pongrac Barlovič
Anže Zorin
Nadan Gregorič
Vladimir Kotnik
author_facet Tjaša Cerar
Draženka Pongrac Barlovič
Anže Zorin
Nadan Gregorič
Vladimir Kotnik
author_sort Tjaša Cerar
collection DOAJ
description <p>To add new evidence that complement activation by the mannan (lectin) pathway is involved in the pathogenesis of nephropathy in patients with type 2 diabetes, we collected blood and urine samples from 20 patients with type 2 diabetes and nephropathy and 20 apparently healthy individuals from the general population. We performed tests for complement activation analysis (CH50, APH50, C3, C4, C3d/dg, C4d, SC5b-9, MBL and genotyping of <em>Mbl2</em> gene) in blood and (C3d/dg, C4d,  MBL, and SC5b-9) in urine. We found significant signs of complement activation in patients with type 2 diabetes and nephropathy in blood and in urine. We also observed significant genetic differences between healthy individuals and patients with type 2 diabetes and nephropathy concerning the <em>Mbl2</em> gene. Healthy individuals were apparently more heterogeneous (45 % A0 type) in presentation of the structural <em>Mbl2</em> genotype, giving intermediate and low levels of MBL protein, compared to patients with type 2 diabetes and nephropathy, who had a very homogenous <em>Mbl2</em> genome (75 % AA type) giving a high level of MBL production. From our data we can conclude that patients with type 2 diabetes and nephropathy presents more frequently with <em>Mbl2</em> gene polymorphism giving high production of the MBL protein, what is very likely connected with acquired renal injury.</p>
first_indexed 2024-04-13T20:48:33Z
format Article
id doaj.art-ecad86b01de14160b268f3aa3dd2d090
institution Directory Open Access Journal
issn 1318-0347
1581-0224
language English
last_indexed 2024-04-13T20:48:33Z
publishDate 2014-11-01
publisher Slovenian Medical Association
record_format Article
series Zdravniški Vestnik
spelling doaj.art-ecad86b01de14160b268f3aa3dd2d0902022-12-22T02:30:37ZengSlovenian Medical AssociationZdravniški Vestnik1318-03471581-02242014-11-018310934Activation of complement system by mannan pathway and Mbl2 genotypes in patients with type 2 diabetes and nephropathyTjaša Cerar0Draženka Pongrac Barlovič1Anže Zorin2Nadan Gregorič3Vladimir Kotnik4Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Zaloška 4, 1000 Ljubljana, SloveniaClinical Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Center Ljubljana, Zaloška 7, 1000 Ljubljana, SloveniaInstitute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Zaloška 4, 1000 Ljubljana, SloveniaClinical Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Center Ljubljana, Zaloška 7, 1000 Ljubljana, SloveniaInstitute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Zaloška 4, 1000 Ljubljana, Slovenia<p>To add new evidence that complement activation by the mannan (lectin) pathway is involved in the pathogenesis of nephropathy in patients with type 2 diabetes, we collected blood and urine samples from 20 patients with type 2 diabetes and nephropathy and 20 apparently healthy individuals from the general population. We performed tests for complement activation analysis (CH50, APH50, C3, C4, C3d/dg, C4d, SC5b-9, MBL and genotyping of <em>Mbl2</em> gene) in blood and (C3d/dg, C4d,  MBL, and SC5b-9) in urine. We found significant signs of complement activation in patients with type 2 diabetes and nephropathy in blood and in urine. We also observed significant genetic differences between healthy individuals and patients with type 2 diabetes and nephropathy concerning the <em>Mbl2</em> gene. Healthy individuals were apparently more heterogeneous (45 % A0 type) in presentation of the structural <em>Mbl2</em> genotype, giving intermediate and low levels of MBL protein, compared to patients with type 2 diabetes and nephropathy, who had a very homogenous <em>Mbl2</em> genome (75 % AA type) giving a high level of MBL production. From our data we can conclude that patients with type 2 diabetes and nephropathy presents more frequently with <em>Mbl2</em> gene polymorphism giving high production of the MBL protein, what is very likely connected with acquired renal injury.</p>http://vestnik.szd.si/index.php/ZdravVest/article/view/103nephropathy, diabetes, complement, mannan binding lectin
spellingShingle Tjaša Cerar
Draženka Pongrac Barlovič
Anže Zorin
Nadan Gregorič
Vladimir Kotnik
Activation of complement system by mannan pathway and Mbl2 genotypes in patients with type 2 diabetes and nephropathy
Zdravniški Vestnik
nephropathy, diabetes, complement, mannan binding lectin
title Activation of complement system by mannan pathway and Mbl2 genotypes in patients with type 2 diabetes and nephropathy
title_full Activation of complement system by mannan pathway and Mbl2 genotypes in patients with type 2 diabetes and nephropathy
title_fullStr Activation of complement system by mannan pathway and Mbl2 genotypes in patients with type 2 diabetes and nephropathy
title_full_unstemmed Activation of complement system by mannan pathway and Mbl2 genotypes in patients with type 2 diabetes and nephropathy
title_short Activation of complement system by mannan pathway and Mbl2 genotypes in patients with type 2 diabetes and nephropathy
title_sort activation of complement system by mannan pathway and mbl2 genotypes in patients with type 2 diabetes and nephropathy
topic nephropathy, diabetes, complement, mannan binding lectin
url http://vestnik.szd.si/index.php/ZdravVest/article/view/103
work_keys_str_mv AT tjasacerar activationofcomplementsystembymannanpathwayandmbl2genotypesinpatientswithtype2diabetesandnephropathy
AT drazenkapongracbarlovic activationofcomplementsystembymannanpathwayandmbl2genotypesinpatientswithtype2diabetesandnephropathy
AT anzezorin activationofcomplementsystembymannanpathwayandmbl2genotypesinpatientswithtype2diabetesandnephropathy
AT nadangregoric activationofcomplementsystembymannanpathwayandmbl2genotypesinpatientswithtype2diabetesandnephropathy
AT vladimirkotnik activationofcomplementsystembymannanpathwayandmbl2genotypesinpatientswithtype2diabetesandnephropathy